Norwegian version of this page

Xuan Thang Nguyen

Image of Xuan Thang Nguyen
Room 2264
Username
Visiting address Domus Medica Gaustad Sognsvannsveien 9 2nd floor 0372 OSLO

Academic interests

I am passionate about studying epigenetics, especially its role in gene expression within cancer and developmental biology, where abnormal regulation can lead to shifts in cell programming. I’m eager to integrate wet-lab and bioinformatics approaches to explore multiomics for understanding epigenome regulation—utilizing WGS with both short- and long-read sequencing, transcription factor analysis, RNA-seq, ChIP-seq, ATAC-seq, and Hi-C sequencing. I’m also interested in investigating how transcription factor mutations and abnormal epigenetic profiles can drive cancer development, using advanced NGS techniques.

Background

I focused on the INO80 chromatin remodeler and its regulation of estrogen receptor (ER) activity in breast cancer models during my Master's degree. My research demonstrated the cooperation and physical interactions between INO80 and ER, enabling dynamic ER regulation in gene expression through RNA-seq, ChIP-seq, and gene knockdown techniques in luminal breast cancer cell lines. Currently, I am working with sarcoma cancer cell lines, where most display a complex genomic structure and regulation of epigenetic aberrations. Using multiomics approaches, I aim to investigate how the interplay of genomic and epigenetic aberrations drives high aggressiveness in osteosarcoma, liposarcoma, and rhabdomyosarcoma.

 

 

Tags: Bioinformatics, Epigenetics, Cancer Epigenetics, Sarcomas, Transcription factor

Publications

1. Yoo, H.; La, H.; Lee, E.J.; Choi, H.-J.; Oh, J.; Thang, N.X.; Hong, K. ATP-Dependent Chromatin Remodeler CHD9 Controls the Proliferation of Embryonic Stem Cells in a Cell Culture Condition-Dependent Manner. Biology 2020, 9, 428. https://doi.org/10.3390/biology9120428

2. Thang, N.X.; Yoo, S.; La, H.; Lee, H.; Park, C.; Park, K.S.; Hong, K. Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer. Biomedicines 2022, 10, 748. https://doi.org/10.3390/biomedicines10040748

3. Yoo S, Lee EJ, Thang NX, La H, Lee H, Park C, Han DW, Uhm SJ, Song H, Do JT, Choi Y, Hong K. INO80 Is Required for the Cell Cycle Control, Survival, and Differentiation of Mouse ESCs by Transcriptional Regulation. International Journal of Molecular Sciences. 2022; 23(23):15402. https://doi.org/10.3390/ijms232315402

4. Thang NX, Han DW, Park C, Lee H, La H, Yoo S, Lee H, Uhm SJ, Song H, Do JT, Park KS, Choi Y, Hong K. INO80 function is required for mouse mammary gland development, but mutation alone may be insufficient for breast cancer. Front Cell Dev Biol. 2023 Nov 1;11:1253274. doi: 10.3389/fcell.2023.1253274. PMID: 38020889; PMCID: PMC10646318.

4.

  • Nguyen, Xuan Thang; Martiensen, Emily Louise Beecher; Abdelhalim, Mohamed; Tran, Trung; Ledsaak, Marit & Rogne, Marie [Show all 8 contributors for this article] (2026). Proteome-wide multi-omics profiling of osteosarcoma transcription factor networks. bioRxiv (preprint article). doi: 10.64898/2026.03.29.714917. Full text in Research Archive

View all works in NVA

Published Nov. 21, 2024 9:54 AM - Last modified Nov. 21, 2024 9:54 AM